Selma Tobudic
- Infectious Diseases top 1%
- Epidemiology top 5%
- Molecular Biology
- Surgery
- Pharmacology top 10%
- Co-authors
- Christina KratzerHeinz BurgmannElisabeth PresterlAndrea LassniggChristina ForstnerHeimo LaglerFlorian ThalhammerW. Graninger
- Topics
- SARS-CoV-2 and COVID-19 Research (16 papers)Antifungal resistance and susceptibility (11 papers)Antimicrobial Resistance in Staphylococcus (10 papers)
In The Last Decade
Selma Tobudic
64 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 117
- Infectious Diseases 987
- Epidemiology 481
- Molecular Biology 235
- Surgery 182
- Pharmacology 162
Countries citing papers authored by Selma Tobudic
This map shows the geographic impact of Selma Tobudic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selma Tobudic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selma Tobudic more than expected).
Fields of papers citing papers by Selma Tobudic
This network shows the impact of papers produced by Selma Tobudic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selma Tobudic. The network helps show where Selma Tobudic may publish in the future.
Co-authorship network of co-authors of Selma Tobudic
This figure shows the co-authorship network connecting the top 25 collaborators of Selma Tobudic. A scholar is included among the top collaborators of Selma Tobudic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selma Tobudic. Selma Tobudic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 11 | |
| 7 | 5 | |
| 8 | 3 | |
| 9 | 50 | |
| 10 | 134 | |
| 11 | 29 | |
| 12 | 4 | |
| 13 | 55 | |
| 14 | 16 | |
| 15 | 22 | |
| 16 | 16 | |
| 17 | 16 | |
| 18 | 2 | |
| 19 | 16 | |
| 20 | 22 |
About Selma Tobudic
Selma Tobudic is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Nephrology, having authored 68 papers that have together received 1.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (16 papers), Antifungal resistance and susceptibility (11 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). The work is most often cited by research in Infectious Diseases (987 citations), Applied Microbiology and Biotechnology (46 citations) and Clinical Biochemistry (126 citations). Selma Tobudic has collaborated with scholars based in Austria, Germany and Vietnam. Frequent co-authors include Christina Kratzer, Heinz Burgmann, Elisabeth Presterl, Andrea Lassnigg, Christina Forstner, Heimo Lagler, Florian Thalhammer, W. Graninger, Wolfgang Poeppl and Christoph Steininger. Their work appears in journals such as PLoS ONE, Applied and Environmental Microbiology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.